Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, et al. 2023 ESC Guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44:3503–626.

Article  PubMed  CAS  Google Scholar 

Finocchiaro G, Westaby J, Sheppard MN, Papadakis M, Sharma S. Sudden cardiac death in young athletes: JACC state-of-the-art review. J Am Coll Cardiol. 2024;83:350–70.

Article  PubMed  Google Scholar 

Krahn AD, Wilde AAM, Calkins H, La Gerche A, Cadrin-Tourigny J, Roberts JD, et al. Arrhythmogenic right ventricular cardiomyopathy. JACC Clin Electrophysiol. 2022;8:533–53.

Article  PubMed  Google Scholar 

Cadrin-Tourigny J, Bosman LP, Nozza A, Wang W, Tadros R, Bhonsale A, et al. A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2022;43:e1–e9.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kohela A, van Rooij E. Fibro-fatty remodelling in arrhythmogenic cardiomyopathy. Basic Res Cardiol. 2022;117:22.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Bradford WH, Zhang J, Gutierrez-Lara EJ, Liang Y, Do A, Wang TM, et al. Plakophilin 2 gene therapy prevents and rescues arrhythmogenic right ventricular cardiomyopathy in a mouse model harboring patient genetics. Nat Cardiovasc Res. 2023;2:1246–61.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hoque MM, Gbadegoye JO, Hassan FO, Raafat A, Lebeche D. Cardiac fibrogenesis: an immuno-metabolic perspective. Front Physiol. 2024;15:1336551.

Article  PubMed  PubMed Central  Google Scholar 

Yeruva S, Waschke J. Structure and regulation of desmosomes in intercalated discs: Lessons from epithelia. J Anat. 2023;242:81–90.

Article  PubMed  Google Scholar 

Göz M, Pohl G, Steinecker SM, Walhorn V, Milting H, Anselmetti D. Arrhythmogenic cardiomyopathy-related cadherin variants affect desmosomal binding kinetics. J Mol Cell Cardiol. 2024;195:36–44.

Article  PubMed  Google Scholar 

Müller L, Hatzfeld M, Keil R. Desmosomes as signaling hubs in the regulation of cell behavior. Front Cell Dev Biol. 2021;9:745670.

Article  PubMed  PubMed Central  Google Scholar 

Chen SN, Gurha P, Lombardi R, Ruggiero A, Willerson JT, Marian AJ. The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. Circ Res. 2014;114:454–68.

Article  PubMed  CAS  Google Scholar 

Heuser A, Plovie ER, Ellinor PT, Grossmann KS, Shin JT, Wichter T, et al. Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet. 2006;79:1081–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Syrris P, Ward D, Evans A, Asimaki A, Gandjbakhch E, Sen-Chowdhry S, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet. 2006;79:978–84.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Christensen AH, Platonov PG, Jensen HK, Chivulescu M, Svensson A, Dahlberg P, et al. Genotype-phenotype correlation in arrhythmogenic right ventricular cardiomyopathy-risk of arrhythmias and heart failure. J Med Genet. 2022;59:858–64.

Article  PubMed  CAS  Google Scholar 

Gerull B, Kirchner F, Chong JX, Tagoe J, Chandrasekharan K, Strohm O, et al. Homozygous founder mutation in desmocollin-2 (DSC2) causes arrhythmogenic cardiomyopathy in the Hutterite population. Circ Cardiovasc Genet. 2013;6:327–36.

Article  PubMed  CAS  Google Scholar 

Schinner C, Xu L, Franz H, Zimmermann A, Wanuske MT, Rathod M, et al. Defective desmosomal adhesion causes arrhythmogenic cardiomyopathy by involving an integrin-αVβ6/TGF-β signaling cascade. Circulation. 2022;146:1610–26.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ren J, Hu Z, Wu L, Akdis D, Ye W, Saguner AM, et al. Comprehensive analysis of desmosomal protein remodelling identifies desmocollin-2 as potential biomarker for arrhythmogenic cardiomyopathy. Europace. 2025;27:euaf199.

Kolegraff K, Nava P, Helms MN, Parkos CA, Nusrat A. Loss of desmocollin-2 confers a tumorigenic phenotype to colonic epithelial cells through activation of Akt/β-catenin signaling. Mol Biol Cell. 2011;22:1121–34.

Article  PubMed  PubMed Central  CAS  Google Scholar 

James CA, Jongbloed JDH, Hershberger RE, Morales A, Judge DP, Syrris P, et al. International evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework. Circ Genom Precis Med. 2021;14:e003273.

Article  PubMed  CAS  Google Scholar 

Kant S, Holthöfer B, Magin TM, Krusche CA, Leube RE. Desmoglein 2-dependent arrhythmogenic cardiomyopathy is caused by a loss of adhesive function. Circ Cardiovasc Genet. 2015;8:553–63.

Article  PubMed  CAS  Google Scholar 

Christensen AH, Schmitz B, Andersen CB, Bundgaard H, Brand SM, Svendsen JH. Functional promoter variant in desmocollin-2 contributes to arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2016;9:384–7.

Article  PubMed  Google Scholar 

Chen L, Hu Y, Saguner AM, Bauce B, Liu Y, Shi A, et al. Natural history and clinical outcomes of patients with DSG2/DSC2 variant-related arrhythmogenic right ventricular cardiomyopathy. Circulation. 2025;151:1213–30.

Article  PubMed  CAS  Google Scholar 

Zou Y, Lu J, Lian Z, Jia J, Shen J, Li Q, et al. Modified mRNA treatment restores cardiac function in desmocollin-2-deficient mouse models of arrhythmogenic right ventricular cardiomyopathy. Circulation. 2025;151:1780–96.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Beffagna G, Occhi G, Nava A, Vitiello L, Ditadi A, Basso C, et al. Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res. 2005;65:366–73.

Article  PubMed  CAS  Google Scholar 

Dubash AD, Kam CY, Aguado BA, Patel DM, Delmar M, Shea LD, et al. Plakophilin-2 loss promotes TGF-β1/p38 MAPK-dependent fibrotic gene expression in cardiomyocytes. J Cell Biol. 2016;212:425–38.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang Y, Ye Y, Lin X, Wu K, Yu M. Inhibition of pirfenidone on TGF-beta2 induced proliferation, migration and epithlial-mesenchymal transition of human lens epithelial cells line SRA01/04. PLoS One. 2013;8:e56837.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Burghardt I, Tritschler F, Opitz CA, Frank B, Weller M, Wick W. Pirfenidone inhibits TGF-beta expression in malignant glioma cells. Biochem Biophys Res Commun. 2007;354:542–7.

Article  PubMed  CAS  Google Scholar 

Hamidi SH, Kadamboor Veethil S, Hamidi SH. Role of pirfenidone in TGF-β pathways and other inflammatory pathways in acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection: a theoretical perspective. Pharmacol Rep. 2021;73:712–27.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Conte E, Gili E, Fagone E, Fruciano M, Iemmolo M, Vancheri C. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. Eur J Pharm Sci. 2014;58:13–9.

Article  PubMed  CAS  Google Scholar